Wellington Management Group
VRCA icon

Wellington Management Group’s Verrica Pharmaceuticals VRCA Stock Holding History

Wellington Management Group’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,436
Closed -$166K – 2040
2024
Q3 		$166K Sell
11,436
-556
-5% -$25K ﹤0.01% 1896
2024
Q2 		$874K Buy
11,992
+1,753
+17% +$135K ﹤0.01% 1702
2024
Q1 		$606K Buy
+10,239
New +$565K ﹤0.01% 1787
2018
Q3 		– Sell
-4,028
Closed -$795K – 2318
2018
Q2 		$795K Buy
+4,028
New +$789K ﹤0.01% 1941

Other funds holding VRCA

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group's VRCA Position: Q4 2024 in Review

Wellington Management Group sold out of Verrica Pharmaceuticals (VRCA) in Q4 2024, closing a stake of 11,436 shares — an estimated $166K sold.

Wellington Management Group first reported a position in VRCA in Q2 2018 and held it in 4 quarters. The position peaked at $874K in Q2 2024. 81 funds tracked by Wall St. Rank hold VRCA as of Q4 2024.

  • Wellington Management Group reported no remaining Verrica Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Wellington Management Group sold 11,436 Verrica Pharmaceuticals shares in Q4 2024, an estimated $166K.
  • Wellington Management Group first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Wellington Management Group's Verrica Pharmaceuticals position peaked at $874K in Q2 2024.
  • 81 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2024.

Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.